Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|April 18, 2014
Dynamic kinetic resolution of dehydrocoronamic acidDavid A Chaplin, Martin E Fox, Sebastian H B KrollChemmedchem|January 27, 2017
Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling StudyPascale Hazel, Sebastian H B Kroll, Alexander Bondke, et al.Medchemcomm|December 17, 2013
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 InhibitorsPaolo Di Fruscia, Ka-Kei Ho, Sasiwan Laohasinnarong, et al.Nature Communications|March 14, 2024
High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug designVictoria I Cushing, Adrian F Koh, Junjie Feng, et al.Molecular Cancer Therapeutics|March 17, 2018
ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer TreatmentHetal Patel, Manikandan Periyasamy, Georgina P Sava, et al.Cancer Research|July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activitySimak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.Journal of Medicinal Chemistry|November 18, 2010
A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administrationDean A Heathcote, Hetal Patel, Sebastian H B Kroll, et al.Pageof 1